Intellia Therapeutics Stock Moves Higher After Capital Raise Of $600M Issued At $145/Share

by Vandana Singh, Benzinga Editor

June 30, 2021 7:11 AM | 1 min read |

Intellia Therapeutics Inc NTLA has priced a previously announced public offering at $145 per share, representing a discount of 4.4% from the last close price of $151.6 on Tuesday.
The company is offering around 4.1 million shares, and underwriters can purchase up to an additional 620,689 shares.
Gross proceeds will be approximately $600 million.
Goldman Sachs & Co. LLC, Jefferies, SVB Leerink, and Barclays are the joint book-running managers for the offering.
Truist Securities is acting as co-manager for the offering.
The offering will close by July 2.
Price Action: NTLA shares are up 1.71% at $154.20 during the premarket session on the last check Wednesday.